Validate User

Our new paper is out. We are building the case for a shorter duration in uncomplicated candidemia. In this pooled data study, most of the antifungal activity happens in the first week. #candida #mycology #rezafungin @msgerc.bsky.social academic.oup.com/ofid/advance...

Rezafungin – Ein neues Echinocandin für Hefe & Schimmel - Giftiger Dienstag Rezafungin, der neueste Echinocandinvertreter. Gezielt eingesetzt, klug entschieden, bessere Ergebnisse. Candida auris. Pneumocystis jirovecciii. Aspergillus & Candida.

🦠 Neues zu #Candida & #Aspergillus!
GiDi LIVE Webinar-Aufzeichnung zu #Rezafungin & moderner Mykologie-Diagnostik.
Registrierung dauert nur Sekunden.
👉 giftigerdienstag.at/rezafungin-e...

Endophthalmitis—a severe intraocular infection often caused by #CandidaAlbicans can lead to permanent vision loss if not treated promptly. New study examines efficacy of #rezafungin:
www.paijournal.com/index.php/pa... #FungalInfections #MedicalResearch #Ophthalmology

📊 #Rezafungin in real life 🌍🇪🇺🇺🇸

💉 Weekly echinocandin in invasive candidiasis/candidemia
🏥 15 pts | 4 countries
✅ Feasible for outpatients
💪 Active vs resistant #Candida
🛑 Access + admin barriers
👉 Real-world insights!

onlinelibrary.wiley.com/doi/epdf/10....

Rezafungin Utilisation in Real Life—FungiScope Results From Europe and the United States Background Rezafungin, a novel echinocandin with once-weekly intravenous dosing, offers potential advantages for outpatient parenteral antifungal therapy (OPAT) in invasive candidiasis (IC). While c.....

Real-world data from EU & US: Rezafungin shows promise for invasive candidiasis in OPAT - effective, well tolerated, but access remains a barrier. Read the new FungiScope study 👉 onlinelibrary.wiley.com/doi/10.1111/...
#InvasiveFungalInfections #Rezafungin #FungiScope

Rezafungin in special populations with candidaemia and/or invasive candidiasis Achieving and maintaining therapeutic drug exposures with antifungals can be challenging in special patient populations, such as those with organ dysf…

New review on #rezafungin in special populations with #candidaemia / invasive #candidiasis! 📢 Findings suggest rezafungin is suitable without dose adjustments for many groups, including elderly & obese patients. More research needed for other populations. 🔬👉 www.sciencedirect.com/science/arti...

Delighted to present our early experience using rezafungin at the BSAC Winter Conference - managed not to take any photos of the presentation 🙈

Bonus for QE2 having the most picturesque location!

#Infection2024 #rezafungin